Functional role of Epithelial to Mesenchymal Transition in the pathogenesis of I...
Functional role of Epithelial to Mesenchymal Transition in the pathogenesis of Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) defines a group of chronic inflammatory disorders of the digestive tract, with ulcerative colitis and Crohn’s disease being its two major clinical manifestations, affecting 2.5 million people in Eu...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
FLAMINCO
Therapeutic discovery for Inflammatory Bowel Disease
150K€
Cerrado
BFU2012-35999
PAPEL DE LAS CELULAS EPITELIALES INTESTINALES Y SUS PROGENIT...
94K€
Cerrado
GUT TC PHENOTYPES
Regulation of Pathogenic CD4 T Cell Responses in Inflammator...
231K€
Cerrado
PID2019-108996RB-I00
RELEVANCIA FUNCIONAL DE LA FIRMA MOLECULAR EN LAS COMPLICACI...
157K€
Cerrado
SAF2010-20231
RELEVANCIA FISIOPATOLOGICA DE LA EXPRESION GENICA INDUCIDA P...
133K€
Cerrado
INTERCONNECTIONS
Interplay of epithelial mechanics and neutrophil activation...
174K€
Cerrado
Información proyecto INFLEMT
Duración del proyecto: 26 meses
Fecha Inicio: 2021-04-28
Fecha Fin: 2023-06-30
Líder del proyecto
HUMANITAS UNIVERSITY
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
171K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Inflammatory bowel disease (IBD) defines a group of chronic inflammatory disorders of the digestive tract, with ulcerative colitis and Crohn’s disease being its two major clinical manifestations, affecting 2.5 million people in Europe. The high prevalence of IBD in Europe and the multiple clinical challenges associated with a significant degree of unresponsiveness to anti-inflammatory therapies and development of complications requiring surgical intervention demand a deeper understanding of the cellular and molecular mechanisms underpinning IBD.
This project aims to understand the role of the process termed Epithelial–to–Mesenchymal Transition (EMT), an embryonic cellular trans-differentiation program re-launched in many pathological conditions, in the pathogenesis of IBD. EMT has in fact been detected in the inflamed intestinal mucosa and surrounding fibrotic areas of IBD patients and experimental models of colitis, however whether EMT functionally contributes to the pathogenesis of IBD is poorly understood.
The INFLEMT project aims to: 1) profile EMT in human IBD to identify its cellular features and correlation with the disease stage; 2) elucidate the impact of EMT on the integrity, functionality and regenerative capacity of the intestinal epithelial barrier; 3) explore the effects of EMT on fibrosis development and modulation of the immune response to assess its role in sustaining the chronic intestinal disease.
These objectives will be pursued by utilizing patient-derived biopsies as well as novel mouse models to manipulate EMT in the intestinal epithelium. Comprehensive analysis, including RNA-sequencing and multispectral imaging, of the involved cellular and microenvironmental components (epithelial barrier, immune cells, fibroblasts) will be performed in acute and chronic colitis settings to mechanistically configure EMT as an epithelial injury response and a major functional driver in the pathogenesis of IBD.